Antabio

Biotech & Life Sciences · Labège, France · Founded 2009

Operator of a private European biopharmaceutical company intended to develop novel and highly differentiated antibacterial treatments. The company's resistance-breakers develop stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens, enabling health professionals to get access to medicinal products that help in curing drug-resistant diseases. Keywords: Pharmaceuticals and Biotechnology, Antiinfective Product, Antimicrobial Resistance, Antimicrobial Resistance Treatment, Carbapenem-Resistant, Chronic Pulmonary, Drug Development, Nosocomial Infectious Disease, Nosocomial Pneumonia, Pseudomonas Aeruginosa.

Valuation $100–500M

Revenue <$1M

Headcount <100

Total funding $50–100M

Unlock exact values

Investors

12 investors on Antabio's cap table

Sourced from Dealroom's funding history.

Seed 4 investors entered at this stage

Business Angel Pool

Wellcome Trust

CARB-X

European Innovation Council

Series A 8 investors entered at this stage

iXO Private Equity

BNP Paribas Développement

Irdi Capital Investissement

Turenne Capital

Omnes Capital

Galia Gestion

EIC Fund

AMR Action Fund

Global footprint

Where Antabio has talent and traffic

Workforce by country

5 countries with
team presence

🇫🇷 France76.5%

🇳🇱 Netherlands5.9%

🇮🇪 Ireland5.9%

🇨🇭 Switzerland5.9%

🇬🇧 United Kingdom5.9%

5 countries shown

Talent graph

The shape of Antabio's talent

Dealroom maps Antabio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

4 team members profilednamed & role-tagged by Dealroom

25 employeestotal headcount

2 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Antabio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Antabio

An AI-synthesized read of the highest-engagement posts about Antabio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Antabio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles